We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Government Issues $2 Billion in Operation Warp Speed Contracts for COVID-19 Vaccine, Therapeutic
Government Issues $2 Billion in Operation Warp Speed Contracts for COVID-19 Vaccine, Therapeutic
The federal government has granted two contracts worth more than $2 billion as part of Operation Warp Speed — $1.6 billion to Novavax to manufacture and develop its COVID-19 vaccine candidate, and $450 million to Regeneron Pharmaceuticals to manufacture and supply its antibody cocktail to treat COVID-19.